FDA issued a Warning Letter to Porton Biopharma Limited on 1/19/2017 for a previous inspection.
483 Porton Biopharma Aug 2018

483 Porton Biopharma Aug 2018

Patric Klotzbuecher FDA, Mekonnen Lemma Dechassa FDA, Ramesh Potla FDA$119.00 - Available Now

FDA investigators audited the Porton Biopharma - Salisbury, United Kingdom facility and issued inspectional observations (via FDA 483) on 01 Aug 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Aug 2018
  • Location: Salisbury, United Kingdom
  • FEI: 3011691465
Add To Cart